Vaccine manufacturers are rising in Asia – all of this from the new corona van is known

The shares of the Asian vaccine and diagnostic companies rose strongly on Monday on the Korean and Hong Kong Stock Exchange after the research team reported on finding a new coronavirus branch last week.

Bloomberg news agency tellsthat, for example, the manufacturer of south-korean corona and influenza tests Sugentech was 26 % in the pre -market. Coronary vaccine manufacturer Chellid rose at its best of 17 percent and face mask manufacturer Welcron In turn, 5.6 percent on the Seoul Stock Exchange.

The rise of Asian companies follows the development of US vaccine manufacturers. Friday vaccine manufacturer Modern The share rose by 5.3 percent and Pfizer partnership Biontechin The share rose 1.8 percent.

Risks increase

Research publication about the new coronavirus branch was published on Friday. Fox News by A virus resembling a coovid-19 virus was found by a “bat named” known as Shi Zenglin Research team led.

An expert interviewed by Fox News Marc Siegelin According to Shin, the HKU5-COV-2 virus found by Shin seems capable of infecting people with a mechanism similar to that of the Covid-19 virus found in 2019.

However, according to Siegel, there is a very low probability that the new bat virus would be as big as the corona virus. Siegel says the virus does not seem to stick as easily as the corona and does not seem as dangerous.

Bloomberg news agency point outthat everything is not yet known about the new HKU5-COV-2 virus. According to Bloomberg, tens of thousands of Southeast Asian people may receive some kind of corona -vavigation every year.

In most cases, the symptoms remain mild, which is why they may not be noticed.

In any case, the opportunity for a new pandemic is growing bigger and bigger all the time, Bloomberg writes. According to the news agency, researchers detect an average of three pathogens each year.

Three quarters of them come from animals. The likelihood of animal diseases is increasing, among other things, with the progress of climate change, urbanization and industrial agricultural activities, says Bloomberg.